Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$991.20M
EBITDA Margin
-31.64%
TTM Avg
-36.17%
3Y Avg
-63.38%
5Y Avg
-163.90%
Market Cap
$983.38M
EBITDA Margin
17.12%
TTM Avg
8.95%
3Y Avg
16.20%
5Y Avg
17.02%
Market Cap
$1.02B
EBITDA Margin
8.03%
TTM Avg
9.94%
3Y Avg
10.00%
5Y Avg
10.00%
Market Cap
$979.81M
EBITDA Margin
-114.71%
TTM Avg
-284.80%
3Y Avg
-531.58%
5Y Avg
-445.59%
Market Cap
$1.03B
EBITDA Margin
-0.59%
TTM Avg
3.42%
3Y Avg
-15.99%
5Y Avg
-18.77%
Market Cap
$979.53M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$966.65M
EBITDA Margin
-1113.67%
TTM Avg
-2254.05%
3Y Avg
-2254.05%
5Y Avg
-2254.05%
Market Cap
$1.03B
EBITDA Margin
-351.42%
TTM Avg
-184.18%
3Y Avg
-130.50%
5Y Avg
-161.84%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.00B | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $991.20M | -31.64% | -36.17% | -63.38% | -163.90% |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.38M | 17.12% | 8.95% | 16.20% | 17.02% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 8.03% | 9.94% | 10.00% | 10.00% |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | -114.71% | -284.80% | -531.58% | -445.59% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | -0.59% | 3.42% | -15.99% | -18.77% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.53M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $966.65M | -1113.67% | -2254.05% | -2254.05% | -2254.05% |
| Immatics N.V. (IMTX)vs › | $1.03B | -351.42% | -184.18% | -130.50% | -161.84% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | -1556.38% | -1235.25% | -1029.62% | -1004.15% |
Gross Margin
N/A
EBITDA Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
